A Study of Hydroxychloroquine, Vitamin C, Vitamin D, and Zinc for the Prevention of COVID-19 Infection
Status:
Recruiting
Trial end date:
2025-07-01
Target enrollment:
Participant gender:
Summary
This is a Phase II interventional study testing whether treatment with hydroxychloroquine,
Vitamin C, Vitamin D, and Zinc can prevent symptoms of COVID-19
Phase:
Phase 2
Details
Lead Sponsor:
ProgenaBiome
Collaborator:
DSCS CRO
Treatments:
Ascorbic Acid Ergocalciferols Hydroxychloroquine Vitamin D Vitamins Zinc